期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Cell Reports LetPub Score 8.7
51 ratings
Rate
Reputation 9.3 Influence 8.2 Speed 9.1 | ||||||||||||||||
期刊簡稱 | CELL REP | ||||||||||||||||
ISSN | 2211-1247 | ||||||||||||||||
h-index | 108 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 2.70%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.cell.com/cell-reports/home | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/CELL-REPORTS | ||||||||||||||||
開放訪問 | Yes | ||||||||||||||||
出版商 | Cell Press | ||||||||||||||||
主題領域 | CELL BIOLOGY | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | |||||||||||||||||
創刊年 | 0 | ||||||||||||||||
每年文章數 | 1544每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 92.26% | ||||||||||||||||
OA Related Info | APC: Yes( USD5460; ) APC waiver:Check Notes Other charges: No Keywords: cytology、neuroscience、biochemistry Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2211-1247%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-6 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[Cell Reports] 的評論 | 撰寫評論 |
作者: 仲夏嘉祯 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-29 15:59:25 評論於 Let me talk about my bad experience. I submitted to Cell Reports and was rejected in the first round. After arguing, I was asked for major revisions. However, I was rejected in the second round with three reviewers, with the other two having no objections. It was the one reviewer who made things difficult for me. I am studying the mechanism of protein lactylation modification, and the common practice is to mutate lysine (K) to arginine (R) to simulate the unmodified state. However, this reviewer did not approve of this method from the beginning, questioning the amino acid mutation simulation. If he doesn't approve of this simulation, then all my work is in vain. Forget about other journals, even the main journals of Cell have published several articles on lactylation modifications, all using the same method. What's more, my article also rules out the possibility of dominant lysine acylation modifications at this site, something Cell articles lack. Do these editors have no subjective judgment and just blindly follow the idiotic opinions of reviewers? I'm really speechless!(0) 讚! | 仲夏嘉祯 |
作者: hdjhfjd 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-07 12:32:45 評論於 How many reviewers are there for Cell Reports?(0) 讚! | hdjhfjd |
作者: hdjhfjd 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-07 12:31:59 評論於 nar did not pass the review, try submitting to pnas instead, if not, then try cell reports(0) 讚! | hdjhfjd |
作者: 中一区 領域: 生物学 審稿時間: 4.0 month(s) 結果: 拒稿 撰寫評論 |
2024-02-23 17:05:06 評論於 I received an email from Nar for review today, probably being rejected as well. I previously submitted to the Journal of Advanced Research and was also rejected instantly. It's too difficult(0) 讚! | 中一区 |
作者: 首龚 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-22 20:23:51 評論於 The manuscript was not submitted for review and was rejected the next day(0) 讚! | 首龚 |
作者: 中一区 領域: 生物学 審稿時間: 4.0 month(s) 結果: 拒稿 撰寫評論 |
2024-02-22 19:35:43 評論於 Has the document been submitted for review?(0) 讚! | 中一区 |
作者: 首龚 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-22 19:28:07 評論於 Plant cell, NAR, PNAS all rejected. Just submitted to Cell Reports. Wish me luck!(0) 讚! | 首龚 |
作者: Carter Cromwell 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-06 22:39:09 評論於 Why do we have to invest in this? It's such a scam(0) 讚! | Carter Cromwell |
作者: Carter Cromwell 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-06 22:26:38 評論於 Review speed: 2.0 | Submission success rate: 50.0 Research focus: molecular biology Experience sharing: Difficult, low impact factor, not cost-effective(0) 讚! | Carter Cromwell |
作者: 慈悲鸿福 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-22 21:39:43 評論於 Submitted in June, accepted in January of this year, taking 7 months in total(0) 讚! | 慈悲鸿福 |
作者: 一吃就胖小红霞 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-21 23:18:29 評論於 Please translate the following passage into English and Japanese(0) 讚! | 一吃就胖小红霞 |
作者: 佛光运盛 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-16 15:00:44 評論於 Can the impact factor increase this year?(0) 讚! | 佛光运盛 |
作者: 慈悲鸿福 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-29 09:19:45 評論於 How are you doing, friend?(0) 讚! | 慈悲鸿福 |
作者: 是你的寻山呀 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-26 13:21:10 評論於 Hello, may I ask how long it takes for you to reply after an argument? Do you make changes or revisions?(0) 讚! | 是你的寻山呀 |
作者: 黯然采香 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-13 09:40:02 評論於 Research focus: Tumor experience sharing: The quality of the article is very good, I don't understand why it has not been ranked higher than 10? Could it be that it is not publishing enough review articles? Many articles are obviously better than some 10+ journals ?(0) 讚! | 黯然采香 |
作者: 东风谷安蕾 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-19 14:17:15 評論於 According to the external audit, communication will be done via email(0) 讚! | 东风谷安蕾 |
作者: 慧玲来了 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-14 09:49:17 評論於 Research focus: Medicine; Tumor experience sharing: Is "under review" mean it is under review? Why haven't I received an email?(0) 讚! | 慧玲来了 |
作者: 慧玲来了 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-13 15:47:23 評論於 Main research focus: Medicine; Sharing experience with tumors: Could you please tell me, do the words "under review" mean the submission has been sent? Why haven't I received an email?(0) 讚! | 慧玲来了 |
作者: 慈悲鸿福 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-12 10:57:35 評論於 Where can I see its update status?(0) 讚! | 慈悲鸿福 |
作者: 独孤鸿羽 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-17 13:10:31 評論於 Revision: Revised for over 2 months. Submitted on April 30th, and then went under review again on May 2nd(0) 讚! | 独孤鸿羽 |
作者: 先天名轩 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-29 22:16:40 評論於 Okay(0) 讚! | 先天名轩 |
作者: Noel Madge 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-06 22:25:30 評論於 Almost the same level(0) 讚! | Noel Madge |
作者: 碧桃采阳 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-06 17:23:37 評論於 Research focus: Tumor experience sharing: Do we need to submit all the original data for submission to Cell Report?(0) 讚! | 碧桃采阳 |
作者: 碧桃采阳 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-06 13:14:33 評論於 Research focus: Tumor experience sharing: Do I need to provide all the raw data for Cell Report?(0) 讚! | 碧桃采阳 |
作者: 长安清竹 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-15 16:58:33 評論於 Can you please explain the specific review process, as well as the editor's requirements for image quality?(0) 讚! | 长安清竹 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us